Reduced EZH2 significantly increases the expression of a series of antimetastatic genes, including circ-ADD3, by reducing the level of H3K27me3 in the promoter region to form a regulatory circuit, thereby inhibiting the metastasis of HCC (63). Here, ADD3 is linked to hepatocellular carcinoma.